Oxaliplatin Injection, Solution
Product Images NDC 0781-3317

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 0781-3317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxaliplatin Sandoz 01

Chemical structure diagram of the active ingredient Oxaliplatin, showing its platinum center bonded to a 1,2-diaminocyclohexane ligand and oxalate groups.*

FDA Label Image

Oxaliplatin Sandoz 02

A Kaplan-Meier survival curve chart depicting Disease-Free Survival (DFS) probability over time in months. Two arms are compared: FOLFOX4 (solid line) and LV5FU2 (dashed line). The chart includes the number of events and patients at risk at various time points, with a hazard ratio and p-value indicating statistical analysis results.*

FDA Label Image

Oxaliplatin Sandoz 03

A Kaplan-Meier survival curve graph depicting Disease-Free Survival (DFS) probability over time in months for Stage III patients. It compares two treatment arms: FOLFOX4 (solid line) versus LV5FU2 (dashed line) according to the Dukes C classification. The graph includes a hazard ratio with confidence interval and a p-value from the logrank test.*

FDA Label Image

Oxaliplatin Sandoz 04

A survival curve chart comparing the percentage of patients surviving over a 24-month period for three treatment groups: Oxaliplatin with 5-FU/LV, Oxaliplatin with Irinotecan, and Irinotecan with 5-FU/LV. The chart includes median survival times for each group, with Oxaliplatin plus 5-FU/LV showing the longest median survival at 19.4 months. The y-axis represents the percentage of patients surviving, and the x-axis represents time in months.*

FDA Label Image

Oxaliplatin Sandoz 05

Packaging label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) intravenous solution by Sandoz Inc. The label highlights it is a sterile aqueous solution, preservative free, and single-dose vial only. It includes cautions about cytotoxicity, instructions for dilution, storage conditions, and warnings to keep out of reach of children.*

FDA Label Image

Oxaliplatin Sandoz 06

Packaging label for Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) sterile aqueous solution for intravenous use. It is a single-dose vial, preservative-free, and labeled as a cytotoxic agent. The labeler is Sandoz Inc, with manufacturing details from Germany. The label includes storage instructions and warnings not to mix with sodium chloride solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.